RecallRadar

FDA Drug recall D-0623-2024

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only…

On 2024-08-07 the FDA classified a Class II recall of Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only… by Fdc, citing defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0623-2024
ClassificationClass II
Statusongoing
Initiated2024-07-23
Published2024-08-07
Last updated2026-09-13 11:52 UTC
CompanyFdc
DistributionUS

Product

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Reason

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Identifiers

ndc69315-308-02
ndc69315-308-05
ndc69315-308-10
code_infoLot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0623-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.